Despite having spent nearly $8 million on federal lobbying since 2005, home health products maker Invacare (NYSE:IVC) doesn’t have much to show for its efforts.Invacare has plenty of reasons to lobby Congress, because federal policy has a greater impact on the Elyria, Ohio-based firm than most. Medicare reimbursement rates determine the price that Invacare’s equipment-dealer [...]
[Read more of this report]